Contact homology of toric contact manifolds of Reeb type

We use contact homology to distinguish contact structures on various manifolds. We are primarily interested in contact manifolds which admit an action of Reeb type of a compact Lie group. In such situations it is well known that the contact manifold is then a circle orbi-bundle over a symplectic orbifold. With some extra conditions we are able to compute an invariant, cylindrical contact homology, of the contact structure in terms of some orbifold data, and the first Chern class of the tangent bundle of the base space. When these manifolds are obtained by contact reduction, then the grading of contact homology is given in terms of the weights of the moment map. In many cases, we are able to show that certain distinct toric contact structures are also non-contactomorphic. We also use some more general invariants by imposing extra constraints on moduli spaces of holomorphic curves to distinguish other manifolds in dimension $5.

On the Equivalence Problem for Toric Contact Structures on S^3-bundles over S^2$

We study the contact equivalence problem for toric contact structures on $S^3$-bundles over $S^2$. That is, given two toric contact structures, one can ask the question: when are they equivalent as contact structures while inequivalent as toric contact structures? In general this appears to be a difficult problem. To find inequivalent toric contact structures that are contact equivalent, we show that the corresponding 3-tori belong to distinct conjugacy classes in the contactomorphism group. To show that two toric contact structures with the same first Chern class are contact inequivalent, we use Morse-Bott contact homology. We treat a subclass of contact structures which include the Sasaki-Einstein contact structures $Y^{p,q}$ studied by physicists. In this subcase we give a complete solution to the contact equivalence problem by showing that $Y^{p,q}$ and $Y^{p'q'}$ are inequivalent as contact structures if and only if $p\neq p'$.Comment: 61 page

Caractérisation de Trypanosoma sp chez les animaux domestiques dans quatre foyers de la partie Ouest de la République Démocratique du Congo (RDC)

En vue d’identifier les trypanosomes circulants chez les animaux domestiques de Kinshasa, Mbanza-Ngungu, Masi-Manimba et Mushie et d’en déterminer les prévalences par PCR, une étude longitudinale a été menée. 1653 échantillons sanguins ont été prélevés chez les animaux domestiques dans les foyers de Kinshasa, Mbanza-Ngungu, Masi-Manimba et Mushie, dont 22 cas ont été positif au Trypanosoma congolense Forest, correspondant à une prévalence brute de 1,3%. Pour ce qui est des foyers, Kinshasa a eu une prévalence de 2,5%, Mbanza-Ngungu une prévalence de 2,4%, Masi-Manimba sans aucune prévalence et Mushie une prévalence de 1,3%. En rapport avec les saisons, la saison de pluie a eu une prévalence de 1,4%, alors que la saison sèche en a eu 1,3%. Concernant les espèces, les bovins ont eu une prévalence de 0,9%, les porcins une prévalence de 3,7%, les ovins une prévalence de 1,4% et les caprins une prévalence de 0,7%. Quant au sexe, les mâles ont eu une prévalence de 0,9%, alors que les femelles en ont eu 1,5%. Cette étude a montré que la Trypanosomiase Animale Africaine (TAA) serait en recul chez les animaux de ces quatre foyers. Ainsi, les cliniciens sur terrain devraient réorienter leur stratégie thérapeutique, en intégrant cette nouvelle donne. Mots clés: Trypanosoma sp, Animaux domestiques, Ouest RDCIn order to identify circulating trypanosomes in Kinshasa, Mbanza Ngungu, Masi Manimba and Mushie domestic animals and to determine their prevalence by PCR, a longitudinal study was conducted. 1653 blood samples were collected from domestic animals in the Kinshasa, Mbanza Ngungu, Masi Manimba and Mushie households, of which 22 were positive for Trypanosoma congolense Forest, corresponding to a gross prevalence of 1.3%. As for households, Kinshasa had a prevalence of 2.5%, Mbanza Ngungu a prevalence of 2.4%, Masi Manimba without any prevalence and Mushie a prevalence of 1.3%. In relation to the seasons, the rainy season had a prevalence of 1.4% while the dry season had a prevalence of 1.3%. Regarding species, cattle had a prevalence of 0.9%, pigs a prevalence of 3.7%, sheep a prevalence of 1.4% and goats a prevalence of 0.7%. As for sex, males had a prevalence of 0.9% while females had a prevalence of 1.5%. This study showed that African Animal Trypanosomiasis (AAT) is declining among animals in these four locations Thus, clinicians in the field should take into account this new situation in their therapeutic strategy. Keywords: Trypanosoma sp, Domestic animals, West DR

Effect of symmetry breaking perturbations in the one-dimensional SU(4) spin-orbital model

We study the effect of symmetry breaking perturbations in the one-dimensional SU(4) spin-orbital model. We allow the exchange in spin ($J_1$) and orbital ($J_2$) channel to be different and thus reduce the symmetry to SU(2) $\otimes$ SU(2). A magnetic field $h$ along the $S^z$ direction is also applied. Using the formalism developped by Azaria et al we extend their analysis of the isotropic $J_1=J_2$, h=0 case and obtain the low-energy effective theory near the SU(4) point in the asymmetric case. An accurate analysis of the renormalization group flow is presented with a particular emphasis on the effect of the anisotropy. In zero magnetic field, we retrieve the same qualitative low-energy physics than in the isotropic case. In particular, the massless behavior found on the line $J_1=J_2>K/4$ extends in a large anisotropic region. We discover though that the anisotropy plays its trick in allowing non trivial scaling behaviors of the physical quantities. When a magnetic field is present the effect of the anisotropy is striking. In addition to the usual commensurate-incommensurate phase transition that occurs in the spin sector of the theory, we find that the field may induce a second transition of the KT type in the remaining degrees of freedom to which it does not couple directly. In this sector, we find that the effective theory is that of an SO(4) Gross-Neveu model with an h-dependent coupling that may change its sign as h varies.Comment: 14 pages, 5 Figs, added referenc

Form factors of integrable Heisenberg (higher) spin chains

We present determinant formulae for the form factors of spin operators of general integrable XXX Heisenberg spin chains for arbitrary (finite dimensional) spin representations. The results apply to any "mixed" spin chains, such as alternating spin chains, or to spin chains with magnetic impurities.Comment: 24 page

The development and validation of a scoring tool to predict the operative duration of elective laparoscopic cholecystectomy

Background: The ability to accurately predict operative duration has the potential to optimise theatre efficiency and utilisation, thus reducing costs and increasing staff and patient satisfaction. With laparoscopic cholecystectomy being one of the most commonly performed procedures worldwide, a tool to predict operative duration could be extremely beneficial to healthcare organisations. Methods: Data collected from the CholeS study on patients undergoing cholecystectomy in UK and Irish hospitals between 04/2014 and 05/2014 were used to study operative duration. A multivariable binary logistic regression model was produced in order to identify significant independent predictors of long (> 90 min) operations. The resulting model was converted to a risk score, which was subsequently validated on second cohort of patients using ROC curves. Results: After exclusions, data were available for 7227 patients in the derivation (CholeS) cohort. The median operative duration was 60 min (interquartile range 45–85), with 17.7% of operations lasting longer than 90 min. Ten factors were found to be significant independent predictors of operative durations > 90 min, including ASA, age, previous surgical admissions, BMI, gallbladder wall thickness and CBD diameter. A risk score was then produced from these factors, and applied to a cohort of 2405 patients from a tertiary centre for external validation. This returned an area under the ROC curve of 0.708 (SE = 0.013, p  90 min increasing more than eightfold from 5.1 to 41.8% in the extremes of the score. Conclusion: The scoring tool produced in this study was found to be significantly predictive of long operative durations on validation in an external cohort. As such, the tool may have the potential to enable organisations to better organise theatre lists and deliver greater efficiencies in care

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

Genome-wide association studies (GWAS) have identified numerous common prostate cancer (PrCa) susceptibility loci. We have fine-mapped 64 GWAS regions known at the conclusion of the iCOGS study using large-scale genotyping and imputation in 25 723 PrCa cases and 26 274 controls of European ancestry. We detected evidence for multiple independent signals at 16 regions, 12 of which contained additional newly identified significant associations. A single signal comprising a spectrum of correlated variation was observed at 39 regions; 35 of which are now described by a novel more significantly associated lead SNP, while the originally reported variant remained as the lead SNP only in 4 regions. We also confirmed two association signals in Europeans that had been previously reported only in East-Asian GWAS. Based on statistical evidence and linkage disequilibrium (LD) structure, we have curated and narrowed down the list of the most likely candidate causal variants for each region. Functional annotation using data from ENCODE filtered for PrCa cell lines and eQTL analysis demonstrated significant enrichment for overlap with bio-features within this set. By incorporating the novel risk variants identified here alongside the refined data for existing association signals, we estimate that these loci now explain ∼38.9% of the familial relative risk of PrCa, an 8.9% improvement over the previously reported GWAS tag SNPs. This suggests that a significant fraction of the heritability of PrCa may have been hidden during the discovery phase of GWAS, in particular due to the presence of multiple independent signals within the same regio

Global injury morbidity and mortality from 1990 to 2017 : results from the Global Burden of Disease Study 2017

Correction:Background Past research in population health trends has shown that injuries form a substantial burden of population health loss. Regular updates to injury burden assessments are critical. We report Global Burden of Disease (GBD) 2017 Study estimates on morbidity and mortality for all injuries. Methods We reviewed results for injuries from the GBD 2017 study. GBD 2017 measured injury-specific mortality and years of life lost (YLLs) using the Cause of Death Ensemble model. To measure non-fatal injuries, GBD 2017 modelled injury-specific incidence and converted this to prevalence and years lived with disability (YLDs). YLLs and YLDs were summed to calculate disability-adjusted life years (DALYs). Findings In 1990, there were 4 260 493 (4 085 700 to 4 396 138) injury deaths, which increased to 4 484 722 (4 332 010 to 4 585 554) deaths in 2017, while age-standardised mortality decreased from 1079 (1073 to 1086) to 738 (730 to 745) per 100 000. In 1990, there were 354 064 302 (95% uncertainty interval: 338 174 876 to 371 610 802) new cases of injury globally, which increased to 520 710 288 (493 430 247 to 547 988 635) new cases in 2017. During this time, age-standardised incidence decreased non-significantly from 6824 (6534 to 7147) to 6763 (6412 to 7118) per 100 000. Between 1990 and 2017, age-standardised DALYs decreased from 4947 (4655 to 5233) per 100 000 to 3267 (3058 to 3505). Interpretation Injuries are an important cause of health loss globally, though mortality has declined between 1990 and 2017. Future research in injury burden should focus on prevention in high-burden populations, improving data collection and ensuring access to medical care.Peer reviewe

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

Background: Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of “leaving no one behind”, it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017), we measured progress on 41 of 52 health-related SDG indicators and estimated the health-related SDG index for 195 countries and territories for the period 1990–2017, projected indicators to 2030, and analysed global attainment. Methods: We measured progress on 41 health-related SDG indicators from 1990 to 2017, an increase of four indicators since GBD 2016 (new indicators were health worker density, sexual violence by non-intimate partners, population census status, and prevalence of physical and sexual violence [reported separately]). We also improved the measurement of several previously reported indicators. We constructed national-level estimates and, for a subset of health-related SDGs, examined indicator-level differences by sex and Socio-demographic Index (SDI) quintile. We also did subnational assessments of performance for selected countries. To construct the health-related SDG index, we transformed the value for each indicator on a scale of 0–100, with 0 as the 2\ub75th percentile and 100 as the 97\ub75th percentile of 1000 draws calculated from 1990 to 2030, and took the geometric mean of the scaled indicators by target. To generate projections through 2030, we used a forecasting framework that drew estimates from the broader GBD study and used weighted averages of indicator-specific and country-specific annualised rates of change from 1990 to 2017 to inform future estimates. We assessed attainment of indicators with defined targets in two ways: first, using mean values projected for 2030, and then using the probability of attainment in 2030 calculated from 1000 draws. We also did a global attainment analysis of the feasibility of attaining SDG targets on the basis of past trends. Using 2015 global averages of indicators with defined SDG targets, we calculated the global annualised rates of change required from 2015 to 2030 to meet these targets, and then identified in what percentiles the required global annualised rates of change fell in the distribution of country-level rates of change from 1990 to 2015. We took the mean of these global percentile values across indicators and applied the past rate of change at this mean global percentile to all health-related SDG indicators, irrespective of target definition, to estimate the equivalent 2030 global average value and percentage change from 2015 to 2030 for each indicator. Findings: The global median health-related SDG index in 2017 was 59\ub74 (IQR 35\ub74–67\ub73), ranging from a low of 11\ub76 (95% uncertainty interval 9\ub76–14\ub70) to a high of 84\ub79 (83\ub71–86\ub77). SDG index values in countries assessed at the subnational level varied substantially, particularly in China and India, although scores in Japan and the UK were more homogeneous. Indicators also varied by SDI quintile and sex, with males having worse outcomes than females for non-communicable disease (NCD) mortality, alcohol use, and smoking, among others. Most countries were projected to have a higher health-related SDG index in 2030 than in 2017, while country-level probabilities of attainment by 2030 varied widely by indicator. Under-5 mortality, neonatal mortality, maternal mortality ratio, and malaria indicators had the most countries with at least 95% probability of target attainment. Other indicators, including NCD mortality and suicide mortality, had no countries projected to meet corresponding SDG targets on the basis of projected mean values for 2030 but showed some probability of attainment by 2030. For some indicators, including child malnutrition, several infectious diseases, and most violence measures, the annualised rates of change required to meet SDG targets far exceeded the pace of progress achieved by any country in the recent past. We found that applying the mean global annualised rate of change to indicators without defined targets would equate to about 19% and 22% reductions in global smoking and alcohol consumption, respectively; a 47% decline in adolescent birth rates; and a more than 85% increase in health worker density per 1000 population by 2030. Interpretation: The GBD study offers a unique, robust platform for monitoring the health-related SDGs across demographic and geographic dimensions. Our findings underscore the importance of increased collection and analysis of disaggregated data and highlight where more deliberate design or targeting of interventions could accelerate progress in attaining the SDGs. Current projections show that many health-related SDG indicators, NCDs, NCD-related risks, and violence-related indicators will require a concerted shift away from what might have driven past gains—curative interventions in the case of NCDs—towards multisectoral, prevention-oriented policy action and investments to achieve SDG aims. Notably, several targets, if they are to be met by 2030, demand a pace of progress that no country has achieved in the recent past. The future is fundamentally uncertain, and no model can fully predict what breakthroughs or events might alter the course of the SDGs. What is clear is that our actions—or inaction—today will ultimately dictate how close the world, collectively, can get to leaving no one behind by 2030